Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 4 for:    outlook | Wet Macular Degeneration
Previous Study | Return to List | Next Study

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03844074
Recruitment Status : Completed
First Posted : February 18, 2019
Last Update Posted : May 12, 2021
Sponsor:
Information provided by (Responsible Party):
Outlook Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 23, 2020
Actual Study Completion Date : August 13, 2020
Certification/Extension First Submitted : May 4, 2021